Ontario Ministry of Health and Long-Term Care - Schedule of Laboratory Fees

Public Information

Health Care Providers

News Media

Text Only Version

Schedule of Laboratory Fees

IMMUNOHEMATOLOGY / IMMUNOLOGY

	IMMUNOHEMATOLOGY

L471	Antibody identification, per specimen (see Preamble, paragraph 16(a))	45
L481	Antibody titre per antibody, per specimen - to be claimed only if L471 yields a positive identification	15
L482	Antibody screening (see Preamble, paragraph 16)	20
L473	Parallel titration on two specimens to include confirmation of
	previously detected antibody (see Preamble, paragraph 16b)	75
L490	Blood Group - ABO and RhD (see Preamble, paragraph 16)	18
L493	Blood Group - ABO and Rh phenotype (see Preamble, paragraph 16) . . . . . .	40
L494	Blood Group per antigen (see Preamble, paragraph 16)	8
L492	Crossmatch per unit of blood (see Preamble, paragraph 16)	10
L495	Direct anti-human globulin test (see Preamble, paragraph 16)	4

	IMMUNOLOGY

L567	C₁ esterase inactivator screen	5
L665	C-Reactive protein	6
L660	Cold agglutinins- screen	6
L661	Cold agglutinins - titre	15
L560	Complement proteins - C₁q	12
L551	Complement proteins - C₃ (B₁C)	12
L552	Complement proteins - C₄ (B₁E)	12
L557	Complement proteins - C₅	12
L558	Complement proteins - C₃ proactivator	12
L561	Complement proteins - C₁ esterase inactivator	12
L553	Miscellaneous proteins - Ceruloplasmin	12
L554	Miscellaneous proteins - Transferrin	12
L555	Miscellaneous proteins - Alpha ₁ antitrypsin	12
L556	Miscellaneous proteins - Alpha 2 macroglobulin	12
L576	Cryoglobulin characterization	30
L568	Double gel diffusion, qualitative (Ouchterlony) per antigen: antibodies to food
	antigens (milk, wheat proteins) or fungal antigens (allergic alveolitis screening
	series) - maximum of 4 antisera per patient screen	5
L575	Gammopathy Screen by immunoelectrophoresis or immunofixation
	Serum	120
	Urine	120

NOTE:	Maximum one serum and one urine per patient (see Preamble, paragraph 29)

L655	Pregnancy test (see Preamble, paragraph 25)	6
L550	Single gel diffusion and nephelometric quantitative assays
	Immunoglobulin G, A, D, M	15

NOTE:	15 LMS units applies to each of the listed immunoglobulins

L500	Screen for miscellaneous agglutination reactions (see Preamble, paragraph 24),
	e.g., Rheumatoid factor
	Antithyroid (thyroglobulin or microsomal
	Streptolysin screen	6
L900	Screen by secondary laboratory (see Preamble, paragraph 24)	6
L501	Titre - serial tube single antigen	15
L502	Serial tube 4 or more antigens	30
L596	Sperm antibodies - screen	20
L597	Sperm antibodies - titre	40

	Cellular Assays
L528	Antibody dependent cellular cytotoxicity	200
L533	ATP depletion test	275
L532	Caffeine - halothane contracture test	300
L521	Intracellular leukocyte bacterial killing capacity	100
L522	Leukocyte chemotactic activity	150
L523	Leukocyte phagocytic capacity	40
L524	Lymphocyte activation (transformation) by isotope incorporation (limited
	to 3 mitogens and/or antigens)	200
L525	Lymphocyte surface immunoglobulins by immunofluorescence	200
L526	Lymphocyte T and B cell rosettes	200
L527	Mixed lymphocyte reaction	300
L529	Naturally occurring cell cytotoxicity	200
L520	Nitroblue tetrazolium test - screen for enzyme deficiency	30

	Complement - kinetic (activity) assays
L530	Total hemolytic complement (CH₅₀ non-kit)	40
L531	Complement components (activity assays)	60

	Fluorescent Antibody Tests (Immunofluorescent Studies)
	Tests for serum antibodies to tissue and cell components (Codes L535
	and L544) should be claimed per type of tissue section examined and per
	serum dilution used, irrespective of number of antibodies identified,
	maximum, four slides.

L544	Antinuclear (see Preamble, paragraph 24)	35
L944	Antinuclear by secondary laboratory (see Preamble, paragraph 24)	35
L535	Other antibody tests	50
	Antimitochondrial
	Antithyroid
	Antiadrenal
	antismooth muscle
	Antiparietal
	Antiskin
	Antisperm
L545	Protein deposition in tissues (per tissue examined, any number of antisera, e.g.,
	Immunoglobulin, complement component, fibrinogen and pathogens, etc.)	75
	Histocompatibility Testing
L582	Antibody screening (per panel of 15 antigens)	150
L581	Crossmatch	50
L583	HLA 27 typing	50
L580	Tissue typing	200

	Microbial Immunology
L659	Antistreptolysin O, or anti-DNaseB, titre or micro-technique	25
L662	Complement fixation, screen	20
L663	Complement fixation, titre, single antigen	30
L664	Complement fixation, multiple antigens	50
L503	Febrile agglutinins, slide or tube agglutination	25
L668	Heterophile antibodies-screen (slide or single tube) with or without absorption	5
L670	Heterophile antibodies - with absorption by guinea pig kidney or ox cells, multiple tube titres (Paul Bunnell)	30
L667	Non-cultural direct bacterial antibody or antigen assays by fluorescence, agglutination or ELISA techniques. Not to be claimed with any of the codes listed under cultures and not to include Group A streptococcus or chlamydia	12
L682	For each additional antibody add	4
L683	Non-cultural indirect antibody or antigen assays by fluorescence, agglutination or ELISA techniques	15
L684	For each additional antibody add	5
L319	Hepatitis associated antigen or antibody immunoassay - per assay, e.g., hepatitis B surface antigen or antibody, hepatitis B core antibody,hepatitis A antibody (see Preamble, paragraphs 24 & 28)	28
L919	Hepatitis associated antigen or antibody immunoassay by secondary Laboratory per assay (see Preamble, paragraphs 24 & 28)	28
N.C.	Serology HIV Antibody	NAB
L685	Leukocyte phenotyping by monoclonal antibodies - first antibody	200
L686	Leukocyte phenotyping by monoclonal antibodies - each additional antibody, to a maximum of 20 antibodies	15
L658	Trichinella antibody	6
N.C.	VDRL (patient out of the Province)	5
L680	Virus antibodies - neutralization test	40
L681	Virus antibodies - sucrose gradient separation of IgM plus inhibition test	90
L679	Virus antibodies - hemagglutination inhibition or ELISA technique	30

NOTE:	not to be used for AIDS testing

	Miscellaneous
L599	Cryofibrinogen - qualitative	5
L600	Cryoglobulin - qualitative	5
L601	Cryoglobulin - quantitative	30
L602	Pyroglobulin - qualitative	5
L604	Serum viscosity - relative	10
L603	Serum viscosity - quantitative	20

	Radioimmunoassay - see listings under Immunoassays modifiers (units in addition to units for the basic test where applicable - immunologic procedures)

L610	Concentration of sample before testing (any method)	2
L611	Radio-modification of standard technique utilizing isotope labelled reagents, e.g., anti-insulin, anti-diphtheria, anti-tetanus	50
	- immunoelectrophoresis
	- double diffusion
	- radial diffusion

NOTE:	Radio-modifications other than specifically listed under code L611 are not a benefit as such until approved by the Ministry of Health

N.C.	Preparation of special antigens or antisera	NAB
N.C.	Special investigations	NAB

Call the ministry INFOline at 1-866-532-3161
(Toll-free in Ontario only)
TTY 1-800-387-5559
Hours of operation : 8:30am - 5:00pm

The content of this website is provided for information only. No assurance is given that the content is current or accurate. Users are cautioned against relying upon it without making reference to the regulation in effect defining the Schedule of Benefits as it is published from time to time pursuant to Ontario Regulation 552 under the Health Insurance Act.

| Laboratory Service Fees Menu |
| home | central site | contact us | site map | français |

© Queen's Printer for Ontario, 2002 | Privacy Policy | Disclaimers | Last Modified :



Call the ministry INFOline at 1-866-532-3161 (Toll-free in Ontario only) TTY 1-800-387-5559 Hours of operation : 8:30am - 5:00pm
The content of this website is provided for information only. No assurance is given that the content is current or accurate. Users are cautioned against relying upon it without making reference to the regulation in effect defining the Schedule of Benefits as it is published from time to time pursuant to Ontario Regulation 552 under the Health Insurance Act.